title: Undetectable interleukin (IL)-10 and persistent IL-8 expression early in hyaline membrane disease: a possible developmental basis for the predisposition to chronic lung inflammation in preterm newborns.
abstract: We are interested in determining whether premature birth alters expression of counterregulatory cytokines which modulate lung inflammation. Production of proinflammatory cytokines tumor necrosis factor alpha. IL-1 beta, and IL-8 is regulated in part by the antiinflammatory cytokine IL-10. For preterm newborns with hyaline membrane disease, deficiencies in the ability of lung macrophages to express antiinflammatory cytokines may predispose to chronic lung inflammation. We compared the expression of pro- and antiinflammatory cytokines at the mRNA and protein level in the lungs of preterm and term newborns with acute respiratory failure from hyaline membrane disease or meconium aspiration syndrome. Four sequential bronchoalveolar lavage (BAL) samples were obtained during the first 96 h of life from all patients. All patients rapidly developed an influx of neutrophils and macrophages. Over time, cell populations in both groups became relatively enriched with macrophages. The expression of proinflammatory cytokine mRNA and/or protein was present in all samples from both patient groups. In contrast, IL-10 mRNA was undetectable in most of the cell samples from preterm infants and present in the majority of cell samples from term infants. IL-10 concentrations were undetectable in lavage fluid from preterm infants with higher levels in a few of the BAL samples from term infants. These studies demonstrate that 1) IL-10 mRNA and protein expression by lung inflammatory cells is related to gestational age and 2) during the first 96 h of life neutrophil cell counts and IL-8 expression decrease in BAL from term infants, but remain unchanged in BAL samples from preterm infants.
authors.affiliation: Division of Allergy and Immunology, Women's and Children's Hospital, Los Angeles County, California, USA.
authors.forename: C A
authors.initials: CA
authors.lastname: Jones
authors.forename: R G
authors.initials: RG
authors.lastname: Cayabyab
authors.forename: K Y
authors.initials: KY
authors.lastname: Kwong
authors.forename: C
authors.initials: C
authors.lastname: Stotts
authors.forename: B
authors.initials: B
authors.lastname: Wong
authors.forename: H
authors.initials: H
authors.lastname: Hamdan
authors.forename: P
authors.initials: P
authors.lastname: Minoo
authors.forename: R A
authors.initials: RA
authors.lastname: deLemos
mesh_terms: D018893:Bronchoalveolar Lavage; D016207:Cytokines / Q000235:genetics / Q000276:immunology*; D004797:Enzyme-Linked Immunosorbent Assay; D006801:Humans; D006819:Hyaline Membrane Disease / Q000276:immunology*; D007231:Infant, Newborn; D007234:Infant, Premature; D007249:Inflammation; D007375:Interleukin-1 / Q000235:genetics / Q000276:immunology; D016753:Interleukin-10 / Q000235:genetics / Q000276:immunology; D007376:Interleukin-2 / Q000235:genetics / Q000276:immunology; D016209:Interleukin-8 / Q000235:genetics / Q000276:immunology; D008168:Lung / Q000276:immunology*; D016133:Polymerase Chain Reaction; D012333:RNA, Messenger; D014409:Tumor Necrosis Factor-alpha / Q000235:genetics / Q000276:immunology
chemical_list: D016207:Cytokines; D007375:Interleukin-1; D007376:Interleukin-2; D016209:Interleukin-8; D012333:RNA, Messenger; D014409:Tumor Necrosis Factor-alpha; D016753:Interleukin-10